- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02161445
Systolic Time Intervals in the Diagnosis of Heart Failure in Emergency Departement (STA/AHF)
Systolic Time Intervals: a Diagnostic Tool of Acute Heart Failure in Emergency Departement Settings
the gold standard for the diagnostic of acute heart failure is based on clinical, biological (BNP levels) and echocardiographic findings, but still in some cases, the diagnosis is difficult and requires further investigations.
BNP dosages and echocardiography are not always available in many medical centers, especially in emergency departements, and are expensive.
we investigated the use of alternative methods, such as the systolic time intervals (STI), in the diagnosis of acute heart failure (AHF) in emergency departement patients consulting for dyspnea.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
AHF is a common cause for dyspnea, but still hard to diagnose. in emergency departements, physicians dispose of a variety of techniques helping them to identify patients with acute onset dyspnea due to cardiac causes and allowing them to initiate the appropriate therapeutics.
techniques such as the N type brain natriuretic peptid (NT BNP) dosages and echocardiography, in addition to the clinical exam, are efficient in these cases but they encounter many problems:
- the BNP dosages are non-conclusive in some cases (grey zone) and must be repeated wich takes time.
- echocardiography is operator - dependent technique and could be misleading in some conditions.
- both BNP and echocardiography are expensive and not found in many emergency structures, especially in poor countries.
all the arguments pushed us to investigate other simpler and cheaper techniques to apply in these conditions.
STI is an old technique based on the recording of two parameters: electrocardiogram and phonocardiogram, and from them measuring the different systolic intervals:
- pre-ejection period (PEP): defined as the interval between the beginning of the QRS wave and the first heart sound (B1).
- electro-mechanic activation time (EMAT): defined as the interval between the two heart sounds B1 and B2
- the PEP / EMAT time in acute onset heart failure, the conduction times are increased, due to tissular lesions, which prolong the PEP, also the myocardial contractility is deficient and the heart puts less time to eject the blood volume which decrease the EMAT and in summary the PEP/EMAT is increased significatively.
in this study protocol, we aimed to investigate the diagnostic performance of STI compared to conventional methods in the diagnosis of acute heart failure in emergency department settings.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Emergency Department Monastir, Tunisia 5000
-
Monastir, Emergency Department Monastir, Tunisia 5000, Tunisia, 5000
- Nouira Semir
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- non traumatic dyspnea
- age more than 18 years old.
Exclusion Criteria:
- ECG diagnostic for acute myocardial infarction or ischemic chest pain within the prior 24 hours
- history of a heart transplant
- pericardial effusion
- chest wall deformity suspected of causing dyspnea
- coma, shock,Mechanical Ventilation, vasopressor drugs
- arrhythmia serious and sustained, pace maker severe mitral valve disease, severe pulmonary arterial hypertension
- renal failure with creatinine >350micromol/l
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
AHF group
patients with AHF diagnosed based on clinical, biological and echocardiographic findings.
Two sub-groups of patients were identified within HF group: Patients with reduced (<45%) LVEF (HFrEF) and those with preserved (≥45%) LVEF (HFpEF).
|
STIs were measured using simultaneous recording of the electrocardiogram and acoustic cardiography signals using an analogic numeric system (Biopac Systems, Goleta, CA).
A3-minute acoustic cardiographic tracing for all patients was obtained and stored electronically.
We measured the electromechanical activation time (EMAT) which is the time between the initial deflection of the electrocardiographic Q wave and the first phonocardiographic complex corresponding to the first heart sound (S1).
The left ventricle ejection time (LVET) defined as the interval between the peak components from the S1 and S2 complexes was measured on the same cardiac cycles.
All studies were performed in patients in a semi-recumbent position with head at 30 degrees position.
For each patient, the acoustic cardiographic parameters were calculated from a 10-second free of artifact recording of data averaging 8 to 12 beats measurements.
|
non AHF group
we included patients with acute dyspnea and for whom acute heart failure was excluded
|
STIs were measured using simultaneous recording of the electrocardiogram and acoustic cardiography signals using an analogic numeric system (Biopac Systems, Goleta, CA).
A3-minute acoustic cardiographic tracing for all patients was obtained and stored electronically.
We measured the electromechanical activation time (EMAT) which is the time between the initial deflection of the electrocardiographic Q wave and the first phonocardiographic complex corresponding to the first heart sound (S1).
The left ventricle ejection time (LVET) defined as the interval between the peak components from the S1 and S2 complexes was measured on the same cardiac cycles.
All studies were performed in patients in a semi-recumbent position with head at 30 degrees position.
For each patient, the acoustic cardiographic parameters were calculated from a 10-second free of artifact recording of data averaging 8 to 12 beats measurements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PEP/EMAT values between the AHF and non AHF groups
Time Frame: at admission (an average of 24 hours)
|
compare the PEP/EMAT values between the two study groups: AHF and non-AHF.
the diagnosis of AHF is made based on clinical, BNP, and echocardiographic findings.
|
at admission (an average of 24 hours)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PEP values between the two study groups
Time Frame: at admission (an average of 24 hours)
|
compare the PEP values between the two study groups: AHF and non-AHF.
the diagnosis of AHF is made based on clinical, BNP, and echocardiographic findings.
|
at admission (an average of 24 hours)
|
compare the EMAT values between the two study groups
Time Frame: at admission (an average of 24 hours)
|
compare the EMAT values between the two study groups: AHF and non-AHF.
the diagnosis of AHF is made based on clinical, BNP, and echocardiographic findings.
|
at admission (an average of 24 hours)
|
compare the STI diagnostic performance against BNP
Time Frame: at hospital admission (an average of 24 hours)
|
compare the diagnostic performance, based on the area under curve estimation of the ROC curve, between the STI (PEP, EMAT and PEP/EMAT) and the BNP levels
|
at hospital admission (an average of 24 hours)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nouira Samir, Professor, University Hospital of Monastir
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STI in AHF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyspnea
-
Assistance Publique - Hôpitaux de ParisRecruitingDyspnea Invasive Mechanical Ventilation-associatedFrance
-
Mayo ClinicCompletedShortness of Breath | Cardiac; DyspneaUnited States
-
Qure Healthcare, LLCJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedDyspnea | Unexplained Chronic DyspneaUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedRelationship Between Dyspnea and Ventilatory VariabilityFrance
-
University of MonastirCompleted
-
University of California, Los AngelesNot yet recruitingShortness of Breath/Dyspnea
-
Assistance Publique - Hôpitaux de ParisRecruitingDyspnea and Respiratory Insufficiency in ChildrenFrance
-
Medical University of ViennaRecruitingEchocardiography | Acute DyspneaAustria
-
Intersection Medical, Inc.CompletedPulmonary Congestion | Dyspnea, | Acute Heart Failure SyndromeUnited States
-
University of MonastirCompletedDyspnea; CardiacTunisia
Clinical Trials on the acoustic cardiographic parameters were calculated
-
Uludag UniversityCompletedInguinal Hernia | Cholecystectomy | Thyroidectomy | Colon SurgeryTurkey
-
Ataturk UniversityCompletedAnesthesia, Local | Cesarean Section Complications | HypotensionTurkey